ANNAPOLIS, Md., 27. April 2023 /PRNewswire/ — Alphyn Biologics, ein in der klinischen Phase befindliches Dermatologieunternehmen, das erstklassige Multi-Target-Therapeutika entwickelt, wird auf dem 22nd European Society for Pediatric Dermatology Congress (ESPD), der vom 4. bis 6. Mai in…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.